...
  • About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations
Shopping cart close
Scilex Holding Scilex Holding
  • About
    • Overview
    • Leadership
    • Board Of Directors
    • Our Culture
    • Gallery
  • Product Portfolio
    • Technology
    • Pipeline
    • ZTLido®
    • Elyxyb®
    • Gloperba®
    • Expanded Access Policy
  • Partners
  • Science
    • Medical information U.S.
    • Publications
  • Investors
    • Investors Overview
    • News & Events
    • Presentations
    • SEC Filings
    • Governance
    • Analyst Coverage
    • Contact Investor Relations
    • Stock Information
    • FAQs
  • Join Our Team
  • Contact Us
    • Contact Us
    • Locations

Posts by Jitendra

Home » Articles Posted by Jitendra (Page 26)
10 Dec
Press Release

SCILEX Pharmaceuticals Announces Executive Hires – Expanding team supports the ramp up of pain product suite

  • July 15, 2021
  • Posted by Jitendra
MALVERN, Pa., Dec. 10, 2015 /PRNewswire/ -- SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced the appointment of senior executives as...

Read more

17 Sep
Press Release

FDA Accepts SCILEX Pharmaceuticals’ NDA Filing for ZTlido™

  • July 15, 2021
  • Posted by Jitendra
Malvern, PA, September 16, 2015 – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today announced that the FDA has accepted for filing...

Read more

09 Jun
Press Release

SCILEX Pharmaceuticals Announces Appointments of Internationally Recognized Industry Experts

  • July 15, 2021
  • Posted by Jitendra
Dr. Sanjay Gupta, President of the American Pain Association and a renowned physician with pain management expertise Dr. Philip Gerbino, an award-winning global pharmaceutical consultant and industry expert on market access MALVERN, Pa., June...

Read more

06 Apr
Press Release

SCILEX PHARMACEUTICALS ANNOUNCES STRATEGIC INVESTMENT BY ITOCHU CHEMICAL FRONTIER CORPORATION

  • July 15, 2021
  • Posted by Jitendra
SCILEX PHARMACEUTICALS ANNOUNCES STRATEGIC INVESMENT BY ITOCHU CHEMICAL FRONTIER CORPORATION Malvern, PA – March 19, 2015 – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain, today...

Read more

11 Sep
Press Release

SCILEX TO PRESENT AT AEGIS CAPITAL HEALTHCARE & TECHNOLOGY CONFERENCE

  • July 15, 2021
  • Posted by Jitendra
SCILEX TO PRESENT AT AEGIS CAPITAL HEALTHCARE & TECHNOLOGY CONFERENCE   MALVERN, PA. September 10, 2014 /PRNewswire/ — SCILEX Pharmaceuticals Inc., a company engaged in the development and commercialization of products focused on the treatment of...

Read more

11 Aug
Press Release

SCILEX Pharmaceuticals Featured In Philadelphia Business Journal

  • July 15, 2021
  • Posted by Jitendra
Please click the link below to read the complete article. http://www.bizjournals.com/philadelphia/blog/health-care/2014/08/pain-drug-developer-reels-in-5.html

Read more

05 May
Press Release

SCILEX Pharmaceuticals Appoints Accounting And Finance Veteran Jerrold Sendrow To Board Of Directors

  • July 15, 2021
  • Posted by Jitendra
Mr. Sendrow Joins Pharmaceuticals Product Development and Regulatory Expert Eric Floyd, Ph.D. on the Board Malvern, PA – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products focused on the treatment of pain,...

Read more

24 Mar
Press Release

SCILEX Pharmaceuticals Announces Filing of Investigational New Drug Application for Ztlido™

  • July 15, 2021
  • Posted by Jitendra
Pivotal pharmacokinetic bridging clinical study anticipated to begin in May. Malvern, PA – SCILEX Pharmaceuticals, Inc., a company engaged in the development and commercialization of products for the treatment of pain, today announced that it...

Read more

21 Mar
Press Release

SCILEX Pharmaceuticals Announces Completion of $5,000,000 Private Placement

  • July 15, 2021
  • Posted by Jitendra
Funds to be used for the clinical development of the Company’s first product Ztlido™ (lidocaine patch 1.8%) Malvern, PA – SCILEX Pharmaceuticals, Inc., today announced that the company has entered into definitive agreements for a...

Read more

«‹242526
Close
Recent Posts
  • Nasdaq_Gloperba03
    Gloperba Launch – Nasdaq-2024
    July 10, 2024 No Comments
  • A randomized, placebo-controlled trial of long-acting dexamethasone viscous gel delivered by transforaminal injection for lumbosacral radicular pain
    June 14, 2024 No Comments
  • Gout Awareness Day – May 22
    May 20, 2024 No Comments
  • Decreased Opioid Utilization with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch: A Retrospective Claims Analysis
    March 14, 2024 No Comments
  • Retrospective Claims Analysis of Decreased Healthcare Visits with Lidocaine Topical System 1.8% Compared to Lidocaine 5% Patch
    March 14, 2024 No Comments

scilex-holding-logo-white

Terms of Use  Privacy Policy  Contact

  • Follow us on Facebook
  • Follow us on LinkedIn
  • Contact us by email

©2024 Scilex Holding All Rights Reserved
Scilex Holding Company is the owner of Scilex Pharmaceuticals and Semnur Pharmaceuticals

Scroll To Top Sidebar
We use cookies to improve your experience on our website. By browsing this website, you agree to our use of cookies.
Accept More info